TBPH icon

Theravance Biopharma

94 hedge funds and large institutions have $1.84B invested in Theravance Biopharma in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 37 increasing their positions, 26 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

1.41% more ownership

Funds ownership: 85.37%86.78% (+1.4%)

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

47% less call options, than puts

Call options by funds: $1.06M | Put options by funds: $1.99M

Holders
94
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.06M
Puts
$1.99M
Net Calls
Net Calls Change

Top Buyers

1 +$39.9M
2 +$38.1M
3 +$6.48M
4
BlackRock
BlackRock
New York
+$5.04M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$4.66M

Top Sellers

1 -$18.9M
2 -$14.8M
3 -$7.23M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.34M
5
First Manhattan
First Manhattan
New York
-$3.24M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$427M
2
$369M
3
$313M
4
$145M
5
$127M
6
$69.9M
7
$52.6M
8
$37.8M
9
$35.4M
10
$32M
11
$23.9M
12
$21.1M
13
$18M
14
$14.1M
15
$9.53M
16
$8.85M
17
$8.81M
18
$8.27M
19
$7.17M
20
$7.12M
21
$7.07M
22
$6.48M
23
$6.39M
24
$6.21M
25
$6.14M